Tasman's R-107 is an investigational, Phase 3, extended-release, oral ketamine tablet and monotherapy for patients with treatment resistant depression ("TRD"). BEDROC Phase 2 randomized ...

Phentermine is available as a tablet in brand-name versions called Adipex-P and Lomaira. This article describes the dosages of phentermine’s oral forms ... prescribes 37.5-mg tablets or capsules ...

GSK's Blujepa met primary endpoints in phase 3 trials, showing 58.5% success in EAGLE-3 vs. 43.6% for nitrofurantoin in uUTI treatment. The FDA approved Blujepa for uUTIs in female adults and ...